Exelixis has taken a major step forward in its colorectal cancer development pipeline by securing supplies of Merck’s Keytruda for an upcoming phase 3 clinical
Betty Vertin is a mother, writer and a fierce defender of the decisions she and her husband Jason made about the seven children they brought
According to the CDC, a look back at April 2026 cumulative reports showed more than 139 pediatric deaths with approximately 250,000 people hospitalized. In simple
Atossa Therapeutics Inc. has achieved a significant regulatory milestone with the U.S. Food and Drug Administration’s grant of Rare Pediatric Disease (RPD) designation to (Z)-endoxifen
An article from University of Michigan highlighted Jolanta Grembecka and her husband Tomasz Cierpicki, both assistant professors in U of M’s Department of Pathology, who
Milenia Makani is an abstract artist living in London. She lives with Hypermobile Ehlers-Danlos Syndrome (hEDS), and has launched an international art fundraiser to support
What happens when a pharmaceutical first-mover discovers its historic achievement may not be a blockbuster? Arvinas and Pfizer found an answer this week by handing
What is Parkinson’s Disease – known as PD for short? Parkinson’s Disease was first discovered in 1817 by a British doctor named James Parkinson. From
A recent article by Dr. Rosalie Greenberg explores the possible relationship of infections caused by ticks and psychiatric conditions in children, including PANS or PANDA
Abeona Therapeutics Inc. has announced a significant expansion in access to ZEVASKYN, marking the activation of Children’s Hospital of Philadelphia (CHOP) as the sixth Qualified
As reported on PharmaBiz, Regenxbio has announced encouraging topline findings from the pivotal Phase III portion of its ongoing AFFINITY DUCHENNE clinical program evaluating RGX-202,
Biossil, based in Toronto and co-founded by Dr. Alexander Mosa (Chair, CSO and co-founder) and Anthony Mouchantaf (CEO and co-founder), is making headway for rare
As reported on PharmaTimes, Poolbeg Pharma has secured a Canadian patent protecting the use of p38 MAPK inhibitors, including its lead candidate POLB 001, for preventing
Editor’s Note: This story was originally published on Linked-In and is shared with permission by Olga Lucia Torres. She waited an hour and fifteen minutes to
As reported on Healio, emerging real-world evidence suggests that glucagon-like peptide-1 (GLP-1) receptor agonists—and related dual agonists—may play a significant role in lowering the risk
I remember the day I realized something was wrong, as clearly as if it happened this past weekend. It was a beautiful morning in June.
Systemic lupus erythematosus punishes patients twice. First comes the disease itself, an autoimmune disorder where the body attacks its own tissues, causing debilitating fatigue, joint
As reported on BioSpace, the U.S. Food and Drug Administration (FDA) has approved Partner Therapeutics’ bispecific antibody Bizengri for adults with cholangiocarcinoma harboring an NRG1
🦴 May is Arthritis Awareness Month 💙
Arthritis affects more than 58 million adults in the U.S.—and it’s a leading cause of disability worldwide.
But arthritis isn’t just about aging. It impacts people of all ages, with over 100 different types of arthritis and related conditions.
✨ What you should know:
• Early diagnosis matters
• Staying active can help reduce symptoms
• Awareness leads to better support and care
Let’s work together to raise awareness, support those affected, and promote healthier, more active lives.
#ArthritisAwarenessMonth #ChronicIllness #HealthAwareness #PatientWorthy
May is Celiac Disease Awareness Month 🌾💚
Celiac disease is more than a food intolerance — it’s an autoimmune condition where consuming gluten triggers the immune system to damage the small intestine. While digestive symptoms are common, many people also experience fatigue, anemia, headaches, joint pain, skin issues, or neurological symptoms that often go overlooked or misdiagnosed.
Awareness matters because early diagnosis and treatment can help prevent long-term complications and improve quality of life. Listening to your body, advocating for answers, and understanding the importance of a strict gluten-free lifestyle can make a life-changing difference for those living with this condition.
#CeliacDisease #GlutenFree #PatientWorthy
Getting answers can take time, testing and many appointments. Understanding how Becker muscular dystrophy is diagnosed can help make the process feel a little less overwhelming and bring more clarity to what comes next. 💙
Share your story with us here: bit.ly/4dV7gru
#beckermusculardystrophy #beckermusculardystrophyawareness #bmd #raredisease #shareyourstory #PatientWorthy
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
